Jobs
View more job listings or post a job
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Horizon Therapeutics Director, Bioanalytical Sciences
Exelixis Principal Scientist - DMPK
Post a job


Position:
Associate Director/Director in Laboratory Animal and Exploratory Toxicology

Employer:
Bioduro-Sundia

Description:
1.	Oversee design, execution, data analysis, and report writing of in-life part of pharmacokinetics (DMPK) studies in small and large animals in drug discovery and preclinical development.
2.	Technical guiding on various administration routes such as intragastric, intravenous, intraperitoneal or subcutaneous administration, blood collection, animal anatomy, tissue collection of small and large animals (mice, rats, dogs, monkeys, rabbits, min-pigs, etc.)
3.	Responsible for design, execution, data analysis, date interpretation and report writing of preclinical exploratory toxicology studies in rodents and large animals.
4.	Be responsible for operation, management and training of lab animal group, as well as the group members’ performance review, and cooperating with various functional groups within the department to ensure study completion with high quality on time.
5.	Be responsible for project management, study progress, study tracking and efficient communication with clients.
6.	Excellent written and oral communication skills in Chinese and English, good interpersonal communication and capable leadership
7.	Pay attention to new technologies such as new drug delivery systems in laboratory animal science and build new service capability as needed.


Qualifications/Experience:
1.	A Ph.D. or MS degree in veterinary medicine, medicine, pharmacology, toxicology and other related disciplines with 8 - 15 year working experience in pharmaceutical and biotechnology companies or contract research organizations (CRO).
2.	At least 8-year working experience directly engaged in experimental animals, pharmacokinetics, toxicokinetics, maximum tolerated dose and dose range finding studies.
3.	Strong and wide lab animal experimental technical skills and experience related pharmacokinetics studies.
4.	Working experience and leadership in exploratory or non-GLP toxicology studies including study design, execution, data analysis, report writing and data interpretation between clinical observation and clinical pathology (clinical chemistry, hematology and coagulation) and histopathology results.
5.	Working knowledge and experience in absorption, distribution, metabolism, excretion and toxicology of new chemical entities in various stages of drug discovery and preclinical development.
6.	Extensive experience in managing a large team and having strong capabilities to learn and solve problems. 
7.	Working knowledge with USFDA and NMPA technical guidelines on drug metabolism, pharmacokinetics and toxicokinetics, and experience with international, national and local animal use and care regulations and policies (AAALAC, IACUC, Laboratory Animal Management Committee).


Location: Shanghai

Contact: linda.yu@bioduro-sundia.com

Post Date: 2/27/2024 9:41:33 PM
©Pharmaceutical & BioScience Society, International; Last Modified: 5/6/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Lena Biosciences Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
Submit a Text Ad